Skip to content
AnalystLens

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Jan 12, 2026)

Reports
Regulation FD
Filing Date
Filed January 12, 2026
Period End
January 12, 2026
Security
UNH
In the record · 2016–202610-K1110-Q328-K173

UNH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 173 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Feb ’22Feb ’22
  2. Leadership change8-K · May ’24May ’24

Summary

Summary of the 8-K filed January 12, 2026. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group Inc. (UNH) has filed a Current Report (8-K) on January 12, 2026, primarily to disclose information regarding upcoming investor meetings on January 12, 2026.

During these meetings, the company's senior management intends to reaffirm previously issued guidance for adjusted 2025 earnings per share (EPS), which was originally provided on October 28, 2025. It is crucial for investors to note that the company's financial closing procedures for the full year 2025 are not yet finalized.

Consequently, actual reported results could differ from the reaffirmed expectations. This potential variance is attributed to ongoing financial closing procedures, final adjustments, management review, and other developments that may occur before the official finalization of the 2025 financial results.

Key Highlights

  1. UNH is holding investor meetings on January 12, 2026.
  2. Senior management will reaffirm previously disclosed adjusted 2025 EPS expectations.
  3. The original EPS guidance was provided on October 28, 2025.
  4. Full-year 2025 financial closing procedures are still in progress.
  5. Actual financial results may differ from expectations due to closing procedures and potential adjustments.
  6. This filing serves as a Regulation FD disclosure and is not deemed 'filed' for Section 18 purposes.
  7. The information is not incorporated by reference into other SEC filings unless expressly stated.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The primary purpose of this 8-K filing is to inform investors that UnitedHealth Group's senior management will be meeting with investors and intends to reaffirm the company's previously issued adjusted 2025 earnings per share (EPS) expectations.

  2. When were the original 2025 EPS expectations first disclosed?

    The original adjusted 2025 earnings per share expectations were previously disclosed by the Company on October 28, 2025.

  3. Could the actual 2025 financial results differ from the reaffirmed guidance?

    Yes, the company explicitly states that its financial closing procedures for the full year 2025 are not yet complete. As a result, actual results may change due to final adjustments, management review, and other developments, potentially causing them to fall outside the previously provided ranges.

  4. Does this filing provide updated 2025 financial results?

    No, this filing does not provide updated financial results. It only announces the intention to reaffirm existing guidance and warns that actual results may vary once finalized.